The emergence of ECM mechanics and cytoskeletal tension as important regulators of cell function

Department of Biomedical Engineering, University of California, Irvine, Irvine, California, United States
Cell Biochemistry and Biophysics (Impact Factor: 1.68). 02/2007; 47(2):300-20. DOI: 10.1007/s12013-007-0004-y
Source: PubMed


The ability to harvest and maintain viable cells from mammalian tissues represented a critical advance in biomedical research, enabling individual cells to be cultured and studied in molecular detail. However, in these traditional cultures, cells are grown on rigid glass or polystyrene substrates, the mechanical properties of which often do not match those of the in vivo tissue from which the cells were originally derived. This mechanical mismatch likely contributes to abrupt changes in cellular phenotype. In fact, it has been proposed that mechanical changes in the cellular microenvironment may alone be responsible for driving specific cellular behaviors. Recent multidisciplinary efforts from basic scientists and engineers have begun to address this hypothesis more explicitly by probing the effects of ECM mechanics on cell and tissue function. Understanding the consequences of such mechanical changes is physiologically relevant in the context of a number of tissues in which altered mechanics may either correlate with or play an important role in the onset of pathology. Examples include changes in the compliance of blood vessels associated with atherosclerosis and intimal hyperplasia, as well as changes in the mechanical properties of developing tumors. Compelling evidence from 2-D in vitro model systems has shown that substrate mechanical properties induce changes in cell shape, migration, proliferation, and differentiation, but it remains to be seen whether or not these same effects translate to 3-D systems or in vivo. Furthermore, the molecular "mechanotransduction" mechanisms by which cells respond to changes in ECM mechanics remain unclear. Here, we provide some historical context for this emerging area of research, and discuss recent evidence that regulation of cytoskeletal tension by changes in ECM mechanics (either directly or indirectly) may provide a critical switch that controls cell function.

Download full-text


Available from: Shelly Peyton, May 23, 2015
  • Source
    • "einhart - King et al . 2005 ) and growth ( Yeung et al . 2005 ) . In all these responses , remodeling of the force - bearing actin cytoskeleton plays a central role . By the formation of F - actin stress fibers and the maturation of FAs , the cell - matrix interaction is reinforced in response to stiffer substrates ( Reinhart - King et al . 2005 ; Peyton et al . 2007 ; Byfield et al . 2009 ; Califano and Reinhart - King 2010 ) . Recently , Krishnan and co - workers established the importance of the endothelial response to increased sub - strate stiffness for the regulation of endothelial barrier proper - ties , showing that this is accompanied by increased TFs ( Krishnan et al . 2011 ) . The group o"
    [Show abstract] [Hide abstract]
    ABSTRACT: Although the endothelium is an extremely thin single-cell layer, it performs exceedingly well in preventing blood fluids from leaking into the surrounding tissues. However, specific pathological conditions can affect this cell layer, compromising the integrity of the barrier. Vascular leakage is a hallmark of many cardiovascular diseases and despite its medical importance, no specialized therapies are available to prevent it or reduce it. Small guanosine triphosphatases (GTPases) of the Rho family are known to be key regulators of various aspects of cell behavior and studies have shown that they can exert both positive and negative effects on endothelial barrier integrity. Moreover, extracellular matrix stiffness has now been implicated in the regulation of Rho-GTPase signaling, which has a direct impact on the integrity of endothelial junctions. However, knowledge about both the precise mechanism of this regulation and the individual contribution of the specific regulatory proteins remains fragmentary. In this review, we discuss recent findings concerning the balanced activities of Rho-GTPases and, in particular, aspects of the regulation of the endothelial barrier. We highlight the role of Rho-GTPases in the intimate relationships between biomechanical forces, microenvironmental influences and endothelial intercellular junctions, which are all interwoven in a beautiful filigree-like fashion.
    Full-text · Article · Mar 2014 · Cell and Tissue Research
  • Source
    • "With this in mind it is important to understand the effect of these peculiar changes in cellular and extra-cellular mechanical properties on tumor growth and metastatic potential. The potential influence of mechanical property changes on cell behavior during cancer progression has been discussed in recent commentaries and insight articles (Peyton et al., 2007; Kumar and Weaver, 2009; Fritsch et al., 2010). The underlying idea is that mechanical forces acting on cells can regulate signaling pathways responsible for cell death, division, differentiation, and migration (Assoian and Klein, 2008; Chen, 2008; Mammoto and Ingber, 2009; Nelson and Gleghorn, 2012; West-Foyle and Robinson, 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Malignant transformation, though primarily driven by genetic mutations in cells, is also accompanied by specific changes in cellular and extra-cellular mechanical properties such as stiffness and adhesivity. As the transformed cells grow into tumors, they interact with their surroundings via physical contacts and the application of forces. These forces can lead to changes in the mechanical regulation of cell fate based on the mechanical properties of the cells and their surrounding environment. A comprehensive understanding of cancer progression requires the study of how specific changes in mechanical properties influences collective cell behavior during tumor growth and metastasis. Here we review some key results from computational models describing the effect of changes in cellular and extra-cellular mechanical properties and identify mechanistic pathways for cancer progression that can be targeted for the prediction, treatment, and prevention of cancer.
    Full-text · Article · Jun 2013 · Frontiers in Oncology
  • Source
    • "and 201±2.40 for the nontreated, negative control siRNA-treated and MTA1 siRNA-treated cells, respectively (p<0.05, n = 3 Figure 2C–E). Alterations of the cellular cytoskeleton organization and polarity are also involved in tumor cell metastasis [31] Therefore, we examined the cytoskeleton structures of the MTA1 siRNA-treated cells by confocal microscopy and found that the ‘feet’ of the MTA1 siRNA-treated cells were shortened and that the cellular polarity was weakened compared to the control cells (Figure 2F-H MTA1: red; nuclei: blue). These results further suggest that MTA1 may be involved in the malignant phenotypes of cancer cells, including adhesion, invasiveness, cytoskeletal structure and cell polarity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Human metastasis-associated gene 1 (MTA1) is highly associated with the metastasis of prostate cancer; however, the molecular functions of MTA1 that facilitate metastasis remain unclear. In this study, we demonstrate that the silencing of MTA1 by siRNA treatment results in the upregulation of E-cadherin expression by the phosphorylation of AKT (p-AKT) and decreases the invasiveness of prostate cancer cells. We show that MTA1 is expressed in over 90% of prostate cancer tissues, especially metastatic prostate cancer tissue, comparing to non-expression in normal prostate tissue. RT-PCR analysis and Western blot assay showed that MTA1 expression is significantly higher in highly metastatic prostate cancer PC-3M-1E8 cells (1E8) than in poorly metastatic prostate cancer PC-3M-2B4 cells (2B4). Silencing MTA1 expression by siRNA treatment in 1E8 cells increased the cellular malignant characters, including the cellular adhesive ability, decreased the cellular invasive ability and changed the polarity of cellular cytoskeleton. 1E8 cells over-expressing MTA1 had a reduced expression of E-cadherin, while 1E8 cells treated with MTA1 siRNA had a higher expression of E-cadherin. The expression of phosphorylated AKT (p-AKT) or the inhibition of p-AKT by wortmannin treatment (100 nM) significantly altered the function of MTA1 in the regulation of E-cadherin expression. Alterations in E-cadherin expression changed the role of p-AKT in cellular malignant characters. All of these results demonstrate that MTA1 plays an important role in controlling the malignant transformation of prostate cancer cells through the p-AKT/E-cadherin pathway. This study also provides a new mechanistic role for MTA1 in the regulation of prostate cancer metastasis.
    Full-text · Article · Dec 2012 · PLoS ONE
Show more